GlassScriptPhysician profile
Robert F Wilson
NPI 1285720904
$176,023.00
in general payments reported to CMS, 2019-2025
11 companies · $25K in 2025
The $25K reported for 2025 was more than what 94% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $27K · 2021: $50K · 2022: $32K · 2023: $19K · 2024: $8,694 · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $52K · Food and Beverage: $604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $52,200.00 |
| Food and Beverage | $603.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $174,443.06 | 2019-2025 | Clinical Trial Product |
| Medtronic, INC. | $391.51 | 2021-2025 | Corevalve Evolut R |
| Edwards Lifesciences Corporation | $362.52 | 2019-2025 | Sapien 3 Ultra Resilia |
| Acist Medical Systems, INC. | $255.07 | 2019-2022 | |
| Medtronic Vascular, INC. | $174.95 | 2019 | |
| Heartflow, INC. | $165.49 | 2019-2021 | |
| Abbott Laboratories | $132.48 | 2023 | Coroflow |
| Cardiovascular Systems INC. | $47.66 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.42 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.72 | 2019 | |
| Opsens INC. | $15.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.